Public research preview
John Curtis, Representative disclosure: er Edwards Lifesciences Corporation Common Stock (EW)
Disclosed a buy transaction in er Edwards Lifesciences Corporation Common Stock (EW). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 7 Aug 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 47 days
Timeline
Transaction date
21 Jun 2023
Public disclosure
7 Aug 2023
Now
Tracked today
Filing delay: 47 days
Price movement
Fallback coverage
- Provider
- Fixture market data
- Fetched
- 26 May 2026
No free fixture-market price coverage for unknown ISIN / EW.
Daily stock-price history is unavailable for this signal.
- Fallback transaction price
- Not available
- Fallback disclosure price
- Not available
- Fallback latest price
- Not available
- Pre-disclosure move
- Not available
- Post-disclosure move
- Not available
- Market-adjusted move
- Not available
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Fixture market data daily closes.
Cautions
- Market-price coverage is fixture-backed until a free public provider is connected.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 7 Aug 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%